Martin A. Katzman, BSc, MD, FRCPC

START Clinic for Mood and Anxiety Disorders, Toronto, Ontario, Canada; Department of Psychology, Adler Graduate Professional School, Toronto, Ontario, Canada; Division of Clinical Sciences, The Northern Ontario School of Medicine, Sudbury, Ontario, Canada; Department of Psychology, Lakehead University, Thunder Bay, Ontario, Canada

  • 4Articles
  • 33.2KReads1
  • 2007–2026Active
  • 23Collaborators
  • 132Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Martin A. Katzman, MD, FRCPC, has published extensively on major depressive disorder and mood disorders, focusing on topics such as functional recovery and early optimized treatment. His work includes studies on the detection rates of mood and anxiety disorders in primary care settings and systematic reviews comparing paroxetine to placebo and other treatments for depressive disorders. Katzman has collaborated frequently with co-authors including Diane McIntosh and Kevin D. Kjernisted.

Publications

JCP
The Role of Chronic Anhedonia in the Relationship Between Treatment-Resistant Depression and Suicidality
Original Research

The Role of Chronic Anhedonia in the Relationship Between Treatment-Resistant Depression and Suicidality

September 21, 2026

Chronic anhedonia is significantly associated with an increased risk of suicidal ideation and attempts in patients with treatment-resistant depression.
, , , et al
PCC
Article

Early Optimized Treatment in MDD

September 1, 2016

Delayed depression treatment is associated with poorer clinical outcomes. This review highlights the evidence for a more rapid, individualized treatment approach to improve outcomes for individual patients.
, , , et al
PCC
Article

Rates of Detection of Mood and Anxiety Disorders in Primary Care: A Descriptive, Cross-Sectional Study

April 28, 2011

Read this article to review results from a study that examined the incidence of major depressive disorder, bipolar disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder and...
, ,
JCP
Original Research

Paroxetine Versus Placebo and Other Agents for Depressive Disorders: A Systematic Review and Meta-Analysis

December 14, 2007

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe